Daré Bioscience Announces FDA Clearance of Investigational New Drug (IND) Application for DARE-VVA1, a Novel Intravaginal Formulation of Tamoxifen for Moderate to Severe Dyspareunia, a Symptom of Vulvar and Vaginal Atrophy Associated with Menopause
ソース:
Nasdaq GlobeNewswire
/
07 12 2023 08:00:00 America/New_York
N/A
シェアする